BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24565202)

  • 1. Loss of the putative tumor suppressor protein spinophilin is associated with poor prognosis in head and neck cancer.
    Aigelsreiter AM; Aigelsreiter A; Wehrschuetz M; Ress AL; Koller K; Salzwimmer M; Gerger A; Schauer S; Bauernhofer T; Pichler M
    Hum Pathol; 2014 Apr; 45(4):683-90. PubMed ID: 24565202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma.
    Aigelsreiter A; Ress AL; Bettermann K; Schauer S; Koller K; Eisner F; Kiesslich T; Stojakovic T; Samonigg H; Kornprat P; Lackner C; Haybaeck J; Pichler M
    Br J Cancer; 2013 May; 108(9):1830-7. PubMed ID: 23591196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinicopathological roles of alpha-B-crystallin and p53 expression in patients with head and neck squamous cell carcinoma.
    Boslooper K; Lam AK; Gao J; Weinstein S; Johnson N
    Pathology; 2008 Aug; 40(5):500-4. PubMed ID: 18604737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glyoxalase 1 expression is associated with an unfavorable prognosis of oropharyngeal squamous cell carcinoma.
    Kreycy N; Gotzian C; Fleming T; Flechtenmacher C; Grabe N; Plinkert P; Hess J; Zaoui K
    BMC Cancer; 2017 May; 17(1):382. PubMed ID: 28549423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ELMO3 expression indicates a poor prognosis in head and neck squamous cell carcinoma - a short report.
    Kadletz L; Heiduschka G; Wiebringhaus R; Gurnhofer E; Kotowski U; Haymerle G; Brunner M; Barry C; Kenner L
    Cell Oncol (Dordr); 2017 Apr; 40(2):193-198. PubMed ID: 28039609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas.
    Ohtomo-Oda R; Komatsu S; Mori T; Sekine S; Hirajima S; Yoshimoto S; Kanai Y; Otsuji E; Ikeda E; Tsuda H
    Hum Pathol; 2016 Mar; 49():145-55. PubMed ID: 26826421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.
    Liu Z; Zhang X; Huang D; Liu Y; Zhang X; Liu L; Li G; Dai Y; Tan H; Xiao J; Tian Y
    Med Oncol; 2012 Dec; 29(5):3381-8. PubMed ID: 22815155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
    Zhang Z; Yang XF; Huang KQ; Ren L; Zhao S; Gou WF; Shen DF; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2016 Feb; 37(2):1671-81. PubMed ID: 26311049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC).
    Pectasides E; Rampias T; Sasaki C; Perisanidis C; Kouloulias V; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
    PLoS One; 2014; 9(4):e94273. PubMed ID: 24722213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.
    Pavón MA; Arroyo-Solera I; Téllez-Gabriel M; León X; Virós D; López M; Gallardo A; Céspedes MV; Casanova I; López-Pousa A; Mangues MA; Quer M; Barnadas A; Mangues R
    Oncotarget; 2015 Oct; 6(30):29016-33. PubMed ID: 26359694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LTBP2 is a prognostic marker in head and neck squamous cell carcinoma.
    Han L; Tang MM; Xu X; Jiang B; Huang J; Feng X; Qiang J
    Oncotarget; 2016 Jul; 7(29):45052-45059. PubMed ID: 27281608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low cytoplasmic and nuclear KPNA2 expression in radiotherapy-treated head and neck squamous cell cancer is associated with an adverse outcome.
    Erben PB; Brunner K; Hecht M; Haderlein M; Büttner-Herold M; Agaimy A; Fietkau R; Hartmann A; Distel LV
    Int J Clin Exp Pathol; 2015; 8(12):15814-24. PubMed ID: 26884852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoplasmic ezrin and moesin correlate with poor survival in head and neck squamous cell carcinoma.
    Schlecht NF; Brandwein-Gensler M; Smith RV; Kawachi N; Broughel D; Lin J; Keller CE; Reynolds PA; Gunn-Moore FJ; Harris T; Childs G; Belbin TJ; Prystowsky MB
    Head Neck Pathol; 2012 Jun; 6(2):232-43. PubMed ID: 22228071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma.
    De Herdt MJ; Willems SM; van der Steen B; Noorlag R; Verhoef EI; van Leenders GJ; van Es RJ; KoljenoviÄ S; Baatenburg de Jong RJ; Looijenga LH
    Oncotarget; 2016 Mar; 7(11):13167-81. PubMed ID: 26909606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
    Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
    Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas.
    García-Carracedo D; Villaronga MÁ; Álvarez-Teijeiro S; Hermida-Prado F; Santamaría I; Allonca E; Suárez-Fernández L; Gonzalez MV; Balbín M; Astudillo A; Martínez-Camblor P; Su GH; Rodrigo JP; García-Pedrero JM
    Oncotarget; 2016 May; 7(20):29780-93. PubMed ID: 27119232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of leucine zipper-EF-hand containing transmembrane protein 1 predicts poor prognosis in head and neck squamous cell carcinoma.
    Chen L; Yang Y; Liu S; Piao L; Zhang Y; Lin Z; Li Z
    Biomed Res Int; 2014; 2014():850316. PubMed ID: 24689060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.
    Dixon PR; Au M; Hosni A; Perez-Ordonez B; Weinreb I; Xu W; Song Y; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    Head Neck; 2016 Sep; 38(9):1347-53. PubMed ID: 27002481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between prognosis and regional biomarker profiles in head and neck squamous cell carcinomas.
    Szentkúti G; Dános K; Brauswetter D; Kiszner G; Krenács T; Csákó L; Répássy G; Tamás L
    Pathol Oncol Res; 2015 Jul; 21(3):643-50. PubMed ID: 25547827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.